Susanna Coers Byram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Susanna Coers Byram has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Virginia M. Sanders
7 shared publicationsCraig J. Serpe
6 shared publicationsKathryn J. Jones
6 shared publicationsCynthia A. DeBoy
Loyola University Chicago
3 shared publications- Cynthia A. DeBoy
Department of Cell Biology, Neurobiology, and Anatomy, Loyola University Chicago, 2160 S. 1st Avenue, Maywood, IL 60153, USA
2 shared publications Eileen M. Foecking
Department of Research and Development Services, Edward Hines Jr. VA Hospital, Hines, IL, United States
2 shared publications
Latest Publications
- Open Access
- 6 June 2024
- Published by Frontiers Media SA in Frontiers in Anesthesiology
- Vol. 3, 1422353
Long-term sensorimotor changes after a sciatic nerve block with bupivacaine and liposomal bupivacaine in a high-fat diet/low-dose streptozotocin rodent model of diabetes
Introduction: It is unclear whether patients with diabetes are more susceptible to nerve toxicity of local anesthetics or whether nerve blocks can accelerate the progression of diabetic peripheral neuropathy. Bupivacaine is one of the most widely used local anesthetics for regional anesthesia despite many pre-clinical studies demonstrating neurotoxicity. Herein, we report the long-term functional consequences of sciatic nerve block with bupivacaine and liposomal bupivacaine (Exparel®) in an animal model of diabetes.Methods: Male Sprague Dawley rats were subject to standard chow/vehicle or high-fat diet/low-dose streptozotocin to induce a diabetic phenotype. Animals were then subdivided into groups that received repeated sciatic nerve blocks of saline, bupivacaine, or liposomal bupivacaine. Mechanical allodynia and thermal hyperalgesia were assessed prior to and 12 weeks following nerve blocks utilizing the von Frey and Hargreaves tests, respectively. Exploratory and locomotor activity were assessed with open field testing, and nerve conduction velocity testing was conducted prior to the termination of the study at 28 weeks.Results: Animals in the diabetic group developed sustained hyperglycemia >200 mg/dl and signs of peripheral neuropathy six weeks after treatment with streptozotocin, which persisted until the end of the study. Twelve weeks after a repeated sciatic nerve block with saline, bupivacaine, or liposomal bupivacaine, results indicate significant interaction effects of the disease group (control vs. diabetic) and local anesthetic treatment. Overall, diabetic status resulted in worse sensorimotor function compared to control animals. Treatment with perineural bupivacaine resulted in worse sensorimotor functions in both control and diabetic animals. Furthermore, bupivacaine treatment in diabetic animals with pre-existing neuropathy exacerbated sensorimotor function in some measures. In contrast, liposomal bupivacaine did not appear to cause any negative effects on functional outcomes for control or diabetic animals.Conclusion: Our data indicate that bupivacaine, and not liposomal bupivacaine, causes long-term changes in tactile allodynia, thermal hyperalgesia, locomotor behaviors, and nerve conduction velocity in control as well as a high-fat diet/low-dose streptozotocin rodent model of diabetes. These results highlight the necessity to investigate safe peripheral nerve block strategies to preserve long-term functional independence in patients with or at risk for diabetic peripheral neuropathy.
- 6 June 2024
- Published by Frontiers Media SA in Frontiers in Anesthesiology
- Vol. 3, 1422353
Open AccessLong-term sensorimotor changes after a sciatic nerve block with bupivacaine and liposomal bupivacaine in a high-fat diet/low-dose streptozotocin rodent model of diabetes
Introduction: It is unclear whether patients with diabetes are more susceptible to nerve toxicity of local anesthetics or whether nerve blocks can accelerate the progression of diabetic peripheral neuropathy. Bupivacaine is one of the most widely used local anesthetics for regional anesthesia despite many pre-clinical studies demonstrating neurotoxicity. Herein, we report the long-term functional consequences of sciatic nerve block with bupivacaine and liposomal bupivacaine (Exparel®) in an animal model of diabetes.Methods: Male Sprague Dawley rats were subject to standard chow/vehicle or high-fat diet/low-dose streptozotocin to induce a diabetic phenotype. Animals were then subdivided into groups that received repeated sciatic nerve blocks of saline, bupivacaine, or liposomal bupivacaine. Mechanical allodynia and thermal hyperalgesia were assessed prior to and 12 weeks following nerve blocks utilizing the von Frey and Hargreaves tests, respectively. Exploratory and locomotor activity were assessed with open field testing, and nerve conduction velocity testing was conducted prior to the termination of the study at 28 weeks.Results: Animals in the diabetic group developed sustained hyperglycemia >200 mg/dl and signs of peripheral neuropathy six weeks after treatment with streptozotocin, which persisted until the end of the study. Twelve weeks after a repeated sciatic nerve block with saline, bupivacaine, or liposomal bupivacaine, results indicate significant interaction effects of the disease group (control vs. diabetic) and local anesthetic treatment. Overall, diabetic status resulted in worse sensorimotor function compared to control animals. Treatment with perineural bupivacaine resulted in worse sensorimotor functions in both control and diabetic animals. Furthermore, bupivacaine treatment in diabetic animals with pre-existing neuropathy exacerbated sensorimotor function in some measures. In contrast, liposomal bupivacaine did not appear to cause any negative effects on functional outcomes for control or diabetic animals.Conclusion: Our data indicate that bupivacaine, and not liposomal bupivacaine, causes long-term changes in tactile allodynia, thermal hyperalgesia, locomotor behaviors, and nerve conduction velocity in control as well as a high-fat diet/low-dose streptozotocin rodent model of diabetes. These results highlight the necessity to investigate safe peripheral nerve block strategies to preserve long-term functional independence in patients with or at risk for diabetic peripheral neuropathy.
- Open Access
- 7 July 2022
- Published by Elsevier in Behavioural Brain Research
- Vol. 433, 113998
Testosterone treatment restores vestibular function by enhancing neuronal survival in an experimental closed-head repetitive mild traumatic brain injury model
- 7 July 2022
- Published by Elsevier in Behavioural Brain Research
- Vol. 433, 113998
Open AccessTestosterone treatment restores vestibular function by enhancing neuronal survival in an experimental closed-head repetitive mild traumatic brain injury model
- 19 May 2020
- Published by SAGE Publications in Restorative Neurology and Neuroscience
- Vol. 38 (2) , 173-183
Distinct neurotoxic effects of select local anesthetics on facial nerve injury and recovery
Background: Local anesthetic toxicity has been well-documented to cause neuronal injury, death, and dysfunction, particularly in a susceptible nerve. Objective: To determine whether select local anesthetics affect neuron survival and/or functional re
- 19 May 2020
- Published by SAGE Publications in Restorative Neurology and Neuroscience
- Vol. 38 (2) , 173-183
Distinct neurotoxic effects of select local anesthetics on facial nerve injury and recovery
Background: Local anesthetic toxicity has been well-documented to cause neuronal injury, death, and dysfunction, particularly in a susceptible nerve. Objective: To determine whether select local anesthetics affect neuron survival and/or functional re
- 4 January 2017
- Published by SAGE Publications in Restorative Neurology and Neuroscience
- Vol. 35 (1) , 129-135
Bupivacaine increases the rate of motoneuron death following peripheral nerve injury
Background: Appropriate management of pain after an injury or surgical procedure has been shown to improve patient outcomes. While infrequent, nerve damage resulting from regional anesthesia can be devastating, however the mechanism remains unknown. Local anesthetics are neurotoxic yet are frequently applied to sites where peripheral nerves are regenerating. Therefore, understanding their effects on injured and growing neurons may have important implications for clinical practice. Objective: The purpose of this study was to determine if local anesthetics exacerbate the rate of motoneuron death following axotomy. Methods: Mice were subjected to a unilateral transection of the facial motor nerve, and either normal saline, 2% lidocaine, or 0.75% bupivacaine was placed at the injury site. Four weeks post-axotomy, percent survival was determined by comparing the number of motoneuron cell bodies on the injured side and the uninjured control side. Results: The average facial motoneuron survival in the saline, lidocaine, and bupivacaine groups 4 weeks after axotomy was 80%, 78% and 35%, respectively. Conclusion: Our data suggest that bupivacaine exacerbates levels of cell death in injured motoneurons. It has been proposed that once a nerve is damaged, it becomes more susceptible to injury elsewhere along the nerve. Thus, an improved understanding of the effects of local anesthetics on neuron survival and axon regeneration may lead to strategies to identify patients at higher risk for permanent neural deficits after peripheral nerve blocks and/or decrease the risk of neural deficit following peripheral nerve blocks.
- 4 January 2017
- Published by SAGE Publications in Restorative Neurology and Neuroscience
- Vol. 35 (1) , 129-135
Bupivacaine increases the rate of motoneuron death following peripheral nerve injury
Background: Appropriate management of pain after an injury or surgical procedure has been shown to improve patient outcomes. While infrequent, nerve damage resulting from regional anesthesia can be devastating, however the mechanism remains unknown. Local anesthetics are neurotoxic yet are frequently applied to sites where peripheral nerves are regenerating. Therefore, understanding their effects on injured and growing neurons may have important implications for clinical practice. Objective: The purpose of this study was to determine if local anesthetics exacerbate the rate of motoneuron death following axotomy. Methods: Mice were subjected to a unilateral transection of the facial motor nerve, and either normal saline, 2% lidocaine, or 0.75% bupivacaine was placed at the injury site. Four weeks post-axotomy, percent survival was determined by comparing the number of motoneuron cell bodies on the injured side and the uninjured control side. Results: The average facial motoneuron survival in the saline, lidocaine, and bupivacaine groups 4 weeks after axotomy was 80%, 78% and 35%, respectively. Conclusion: Our data suggest that bupivacaine exacerbates levels of cell death in injured motoneurons. It has been proposed that once a nerve is damaged, it becomes more susceptible to injury elsewhere along the nerve. Thus, an improved understanding of the effects of local anesthetics on neuron survival and axon regeneration may lead to strategies to identify patients at higher risk for permanent neural deficits after peripheral nerve blocks and/or decrease the risk of neural deficit following peripheral nerve blocks.
- 1 December 2014
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 28 (6) , 1688-1690
Con: The Challenges of Utilizing Expanded-Criteria Donors for Orthotopic Heart Transplantation
- 1 December 2014
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 28 (6) , 1688-1690
Con: The Challenges of Utilizing Expanded-Criteria Donors for Orthotopic Heart Transplantation
- 1 September 2006
- Published by Elsevier in Experimental Neurology
- Vol. 201 (1) , 212-224
Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells
- 1 September 2006
- Published by Elsevier in Experimental Neurology
- Vol. 201 (1) , 212-224
Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells
- 1 August 2006
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 6 (1-2) , 86-96
Motoneurons and CD4+ effector T cell subsets: Neuroprotection and repair
- 1 August 2006
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 6 (1-2) , 86-96
Motoneurons and CD4+ effector T cell subsets: Neuroprotection and repair
- 31 July 2006
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 176 (1-2) , 34-38
CD4+CD25+ regulatory T cells and CD1-restricted NKT cells do not mediate facial motoneuron survival after axotomy
- 31 July 2006
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 176 (1-2) , 34-38
CD4+CD25+ regulatory T cells and CD1-restricted NKT cells do not mediate facial motoneuron survival after axotomy
- 1 March 2005
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 19 (2) , 173-180
Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice
- 1 March 2005
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 19 (2) , 173-180
Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice
- 31 January 2005
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 19 (1) , 12-19
Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury
- 31 January 2005
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 19 (1) , 12-19
Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury